CBD Life Sciences Inc. (OTCPK: CBDL)
Health Care · Pharmaceuticals · US
$0.00
+100.00% today · 0.0% 1Y
CBD Life Sciences Inc. (OTCPK: CBDL) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.19M and employs 3 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.00.
Tweenvest scores CBD Life Sciences Inc. across four factors: quality 34/100, value 47/100, growth 0/100. Its strongest factor is value.
CBDL price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.19M
- Revenue (TTM)
- $98.32K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 82.12
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 5.93B
- Employees
- 3
- Next earnings
- —
About CBD Life Sciences Inc.
CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol. Their extensive range of natural CBD offerings includes hemp tinctures, topical massage oils, targeted recovery and pain relief balms, dietary aids to support anxiety and restful sleep, various consumable treats, and a dedicated collection of products for animal companions. The company's principal operations are conducted from Scottsdale, Arizona.
- ISIN
- US12482V2025
- Listed since
- Sep 11, 2009
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,190.60 | -3.49% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.85 | -0.84% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.74 | -1.73% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.40 | -0.61% |
Figures last refreshed Aug 18, 2026.